Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Ubiquitin C-terminal hydrolase L1 (UCH-L1) is a deubiquitinating enzyme that is highly expressed in neurons, and gathering evidence indicates that UCH-L1 may play pathogenic roles in many neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease (PD).
|
30429647 |
2018 |
Alzheimer's Disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Our data suggest that the Uch-L1-mediated BACE1 up-regulation could be an important mechanism responsible for Aβ peptides accumulation in vascular injury and indicate that the modulation of the activity of this enzyme could provide new therapeutic strategies in AD.
|
29033830 |
2017 |
Alzheimer's Disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Expert opinion: The loss of UCH-L1 activity coupled with the gain of proteinopathy function are linked to neurodegeneration such as Parkinsonism and Alzheimer's disease.
|
28434268 |
2017 |
Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Taken together, our studies show a causative link between the excessive mitochondrial turnover and the NH2htau-induced in vitro neuronal death, suggesting that pathogenetic tau truncation may contribute to synaptic deterioration in AD by aberrant recruitment of Parkin and UCHL-1 to mitochondria making them more prone to detrimental autophagic clearance.
|
25687137 |
2015 |
Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Further assessment of a link between UCH-L1 function and the pathogenesis of AD requires an analytical method to separately quantify different UCH-L1 forms.
|
23682718 |
2013 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The common SNPs of UCHL1 are not major risk factors for AD.
|
22688354 |
2012 |
Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our data suggest that Uch-L1 could be an attractive target for the development of new therapeutic approaches for AD.
|
22726800 |
2012 |
Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Moreover, the function of UCH-L1 may be lost in the brains of PD and Alzheimer's disease patients.
|
22076440 |
2012 |
Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Aberrant function of UCH-L1 has been associated with neurological disorders such as Parkinson's disease and Alzheimer's disease.
|
21878121 |
2011 |
Alzheimer's Disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
This review focuses on recent findings on the functions and the regulation of UCH-L1, in particular those that relate to PD and AD.
|
17586089 |
2007 |
Alzheimer's Disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
TaqMan PCR assays, and Western blots demonstrated down-regulation of UCHL-1 mRNA and UCHL-1 protein in the cerebral cortex in DLB (either in pure forms, not associated with Alzheimer disease: AD, and in common forms, with accompanying AD changes), but not in PD, when compared with age-matched controls.
|
16380264 |
2006 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We conclude that Y allele and YY genotype of S18Y in the UCH-L1 gene may have a protective effect against sporadic AD in female subjects, probably due to altering the function of UCH-L1 and the interactions among different risk factors.
|
16626667 |
2006 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
There was not association between UCHL1 polymorphism and AD in our sample.
|
16698101 |
2006 |
Alzheimer's Disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Transduction of Uch-L1 protein fused to the transduction domain of HIV-transactivator protein (TAT) restores normal enzymatic activity and synaptic function both in hippocampal slices treated with oligomeric Abeta and in the APP/PS1 mouse model of AD.
|
16923396 |
2006 |
Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
LHGDN |
Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.
|
12160938 |
2002 |